Insider · CIK 0001322846

Horvath Susan

Reports to the SEC for 2 companies · WACONIA, MN

sec.gov

Transactions

Companies

Filings

CIK

0001322846

Forms 4 and 5

Insider transactions

34 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-10-01	Panbela Therapeutics, Inc.Stock Option (right to buy)A Award	V.P. of Finance & CFO	AAward	+25.5K sh	—	—	25,480
2023-03-27	Panbela Therapeutics, Inc.Stock Option (right to buy)A Award	V.P. of Finance & CFO	AAward	+34.4K sh	—	—	34,369
2023-01-30	Panbela Therapeutics, Inc.P Purchase	V.P. of Finance & CFO	PPurchase	+4,444 sh	—	—	17,880
2023-01-30	Panbela Therapeutics, Inc.Warrants (right to buy)P Purchase	V.P. of Finance & CFO	PPurchase	+8,888 sh	—	—	8,888
2021-09-13	Panbela Therapeutics, Inc.Employee Stock Option (right to buy)A Award	V.P. of Finance & CFO	AAward	+12.1K sh	—	—	12,135
2021-03-30	Panbela Therapeutics, Inc.Employee Stock Option (right to buy)A Award	V.P. of Finance & CFO	AAward	+40K sh	—	—	40,000
2020-09-01	Panbela Therapeutics, Inc.Warrant (right to buy)P Purchase	V.P. of Finance & CFO	PPurchase	+2,424 sh	—	—	2,424
2020-09-01	Panbela Therapeutics, Inc.P Purchase	V.P. of Finance & CFO	PPurchase	+2,424 sh	—	—	13,436
2020-06-24	Panbela Therapeutics, Inc.Employee Stock Option (right to buy)A Award	V.P. of Finance & CFO	AAward	+32K sh	—	—	32,000
2020-06-05	Panbela Therapeutics, Inc.Warrant (right to buy)P Purchase	V.P. of Finance & CFO	PPurchase	+2,500 sh	—	—	2,500
2020-06-05	Panbela Therapeutics, Inc.P Purchase	V.P. of Finance & CFO	PPurchase	+2,500 sh	—	—	11,012
2019-09-24	Panbela Therapeutics, Inc.Stock Option (right to buy)A Award	V.P. of Finance & CFO	AAward	+25K sh	—	—	25,000
2019-08-30	Panbela Therapeutics, Inc.P Purchase	V.P. of Finance & CFO	PPurchase	+1,428 sh	—	—	8,512
2019-08-30	Panbela Therapeutics, Inc.Warrant (right to buy)P Purchase	V.P. of Finance & CFO	PPurchase	+1,428 sh	—	—	1,428
2019-06-30	Panbela Therapeutics, Inc.Convertible Promissory NoteC Conversion	V.P. of Finance & CFO	CConversion	−23.6K sh	—	—	0
2019-06-30	Panbela Therapeutics, Inc.C Conversion	V.P. of Finance & CFO	CConversion	+7,084 sh	—	—	7,084
2019-05-21	Panbela Therapeutics, Inc.Employee Stock Option (right to buy)A Award	V.P. of Finance & CFO	AAward	+48.3K sh	—	—	48,300
2019-05-21	Panbela Therapeutics, Inc.Employee Stock Option (right to buy)A Award	V.P. of Finance & CFO	AAward	+9,500 sh	—	—	9,500
2018-12-31	Panbela Therapeutics, Inc.Warrant (right to buy)P Purchase	V.P. of Finance & CFO	PPurchase	+13.5K sh	—	—	13,500
2018-12-31	Panbela Therapeutics, Inc.Convertible Promissory NoteP Purchase	V.P. of Finance & CFO	PPurchase	+23.6K sh	—	—	0
2018-04-17	Panbela Therapeutics, Inc.Employee Stock Option (right to buy)A Award	V.P. of Finance & CFO	AAward	+40K sh	—	—	40,000
2006-08-24	CNS INC /DE/S Sale	VP, International	SSale	−1,100 sh	$26.99	−$29.7K	23,204
2006-05-01	CNS INC /DE/Stock Option (Option to Buy)A Award	VP, International	AAward	+17.6K sh	—	—	17,604
2006-01-30	CNS INC /DE/Stock Option (Option to Buy)M Exercise/Conversion	VP, International	MExercise/Conversion	−2,400 sh	—	—	1,200
2006-01-30	CNS INC /DE/Stock Option (Option to Buy)M Exercise/Conversion	VP, International	MExercise/Conversion	−1,200 sh	—	—	2,400
2006-01-30	CNS INC /DE/M Exercise/Conversion	VP, International	MExercise/Conversion	+10K sh	$3.69	+$36.9K	13,440
2006-01-30	CNS INC /DE/Stock Option (Option to Buy)M Exercise/Conversion	VP, International	MExercise/Conversion	−3,600 sh	—	—	0
2006-01-30	CNS INC /DE/Stock Option (Option to Buy)M Exercise/Conversion	VP, International	MExercise/Conversion	−3,600 sh	—	—	0
2006-01-30	CNS INC /DE/Stock Option (Option to Buy)M Exercise/Conversion	VP, International	MExercise/Conversion	−10K sh	—	—	0
2006-01-30	CNS INC /DE/M Exercise/Conversion	VP, International	MExercise/Conversion	+1,200 sh	$10.06	+$12.1K	24,240
2006-01-30	CNS INC /DE/M Exercise/Conversion	VP, International	MExercise/Conversion	+2,400 sh	$11.37	+$27.3K	23,040
2006-01-30	CNS INC /DE/M Exercise/Conversion	VP, International	MExercise/Conversion	+3,600 sh	$6.05	+$21.8K	20,640
2006-01-30	CNS INC /DE/M Exercise/Conversion	VP, International	MExercise/Conversion	+3,600 sh	$4.38	+$15.8K	17,040
2005-04-25	CNS INC /DE/Stock Option (Option to Buy)A Award	VP, International	AAward	+9,600 sh	—	—	9,600

Recent filings

Accepted (ET)
Oct 34
Horvath Susan0001437749-24-030619
SEC(opens sec.gov)
Mar 294
Horvath Susan0001437749-23-008420
SEC(opens sec.gov)
Feb 14
Horvath Susan0001437749-23-002263
SEC(opens sec.gov)
Sep 154
Horvath Susan0001437749-21-022212
SEC(opens sec.gov)
Apr 14
Horvath Susan0001437749-21-007951
SEC(opens sec.gov)
Sep 14
Horvath Susan0001437749-20-019145
SEC(opens sec.gov)
Jun 264
Horvath Susan0001437749-20-014007
SEC(opens sec.gov)
Jun 94
Horvath Susan0001437749-20-012771
SEC(opens sec.gov)
Sep 264
Horvath Susan0001437749-19-019100
SEC(opens sec.gov)
Sep 44
Horvath Susan0001437749-19-017894
SEC(opens sec.gov)
Jul 24
Horvath Susan0001437749-19-013384
SEC(opens sec.gov)
May 234
Horvath Susan0001437749-19-010778
SEC(opens sec.gov)
Jan 34
Horvath Susan0001437749-19-000209
SEC(opens sec.gov)

Companies

Address

712 VISTA BLVD #305

WACONIA, MN, 55387